Stay updated on IRX-2 Regimen + Nivolumab in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the IRX-2 Regimen + Nivolumab in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IRX-2 Regimen + Nivolumab in Solid Tumors Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The record history shows multiple versions with updates to recruitment status and study status, reflecting ongoing changes to the trial's current state over time.
    Difference
    0.1%
    Check dated 2025-11-03T01:19:15.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    31 days ago
    Change Detected
    Summary
    - Updated operating-status notice and new version tag (v3.2.0) added; old version tag (v3.1.0) removed. The page now provides current status guidance and a newer software/document version.
    Difference
    12%
    Check dated 2025-10-05T10:24:14.000Z thumbnail image
  4. Check
    39 days ago
    Change Detected
    Summary
    Update: version bumped from v3.0.2 to v3.1.0, indicating a new release. No other content changes are indicated.
    Difference
    0.3%
    Check dated 2025-09-28T03:20:32.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2. The 'Back to Top' navigation element was removed.
    Difference
    0.7%
    Check dated 2025-09-13T17:36:43.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.7%
    Check dated 2025-09-06T15:05:26.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location details, while several location-related terms have been removed.
    Difference
    18%
    Check dated 2025-08-30T11:47:23.000Z thumbnail image

Stay in the know with updates to IRX-2 Regimen + Nivolumab in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IRX-2 Regimen + Nivolumab in Solid Tumors Clinical Trial page.